Voltar
Revisão Revisado por pares
BIBTEX RIS

Angiotensin‐converting enzyme inhibitors: Medicinal chemistry and biological actions

1982; Wiley; Volume: 2; Issue: 1 Linguagem: Inglês

10.1002/med.2610020103

ISSN

1098-1128

Autores

Edward W. Petrillo, Miguel A. Ondetti,

Tópico(s)

Vitamin K Research Studies

Resumo

Medicinal Research ReviewsVolume 2, Issue 1 p. 1-41 Article Angiotensin-converting enzyme inhibitors: Medicinal chemistry and biological actions Edward W. Petrillo Jr., Edward W. Petrillo Jr. The Squibb Institute for Medical Research, Post Office Box 4000, Princeton, New Jersey 08540Search for more papers by this authorMiguel A. Ondetti, Miguel A. Ondetti The Squibb Institute for Medical Research, Post Office Box 4000, Princeton, New Jersey 08540Search for more papers by this author Edward W. Petrillo Jr., Edward W. Petrillo Jr. The Squibb Institute for Medical Research, Post Office Box 4000, Princeton, New Jersey 08540Search for more papers by this authorMiguel A. Ondetti, Miguel A. Ondetti The Squibb Institute for Medical Research, Post Office Box 4000, Princeton, New Jersey 08540Search for more papers by this author First published: January/March 1982 https://doi.org/10.1002/med.2610020103Citations: 173AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 J. H. Laragh, in Captopril and Hypertension, D. B. Case, Ed., Plenum, New York, 1980, p. 173. 2 R. C. Heel, R. N. Brogden, T. M. Speight, and G. S. Avery, Drugs, 20, 409 (1980). 3 For a review see M. J. Peach, Physiol. Rev., 57, 313 (1977). 4 For a historical review see J. C. Fasciolo, in Hypertension, J. Genest, E. Koiw, and O. Kuchel, Eds., McGraw-Hill, New York, 1977, p. 134. 5 R. L. Soffer, Ann. Rev. Biochem., 45, 73 (1976). 6 H. Y. T. Yang, E. G. Erdös, and Y. Levin, Biochem. Biophys. Acta, 214, 374 (1970). 7 For a review on Saralasin see Kidney Int. Suppl. 9, 1979. 8 For a review of. M. A. Ondetti and D. W. Cushman, in Biochemical Regulation of Blood Pressure, R. L. Soffer, Ed., Wiley, New York, 1981, p. 165. 9 D. W. Cushman and M. A. Ondetti, in Progress in Medicinal Chemistry, G. P. Ellis and G. B. West, Eds., Elsevier/North Holland, Amsterdam, 1979, Vol. 17, p. 41. 10 S. L. Engel, T. R. Schaeffer, B. I. Gold, and B. Rubin, Proc. Soc. Exp. Biol. Med., 140, 240 (1972). 11 H. Gavras, H. R. Brunner, J. H. Laragh, J. E. Sealey, I. Gavras, and R. A. Vukovich, New Eng. J. Med., 291, 817 (1974). 12 M. A. Ondetti, B. Rubin, and D. W. Cushman, Science, 196, 441 (1977). 13 D. W. Cushman, H. S. Cheung, E. F. Sabo, and M. A. Ondetti, Biochemistry, 16, 5484 (1977). 14 J. A. Hartsuck and W. N. Lipscomb, in The Enzymes, P. D. Boyer, Ed., Academic, New York, (1971, Vol. 3, p. 1. 15 M. E. Schmid and J. R. Herriot, J. Mol. Biol., 103, 175 (1976). 16 B. W. Matthews, L. H. Weaver, and W. R. Kestov, J. Biol. Chem., 249, 8030 (1974). 17 W. N. Lipscomb, Tetrahedron, 30, 1725 (1974). 18 W. R. Kester and B. W. Matthews, Biochemistry, 16, 2506 (1977). 19 L. H. Weaver, W. R. Kester, and B. W. Matthews, J. Mol. Biol., 114, 119 (1977). 20 L. D. Byers and R. Wolfenden, Biochemistry, 12, 2070 (1973). 21 M. A. Ondetti, M. E. Condon, J. Reid, E. F. Sabo, H. S. Cheung, and D. W. Cushman, Biochemistry, 18, 1427 (1979). 22 M. S. Rohrbach, E. B. Williams and R. A. Rolstad, J. Biol. Chem., 256, 225 (1981). 23 H. S. Cheung, F. L. Wang, M. A. Ondetti, E. F. Sabo, and D. W. Cushman, J. Biol. Chem., 255, 401 (1980). 24 A. A. Patchett, E. Harris, E. W. Tristram, M. J. Wyvratt, M. T. Wu, D. Taub, E. R. Peterson, T. J. Ikeler, J. ten Broeke, L. G. Payne, D. L. Ondeyka, E. D. Thorsett, W. J. Greenlee, N. S. Lohr, R. D. Hoffsommer, H. Joshua, W. V. Ruyle, J. W. Rothrock, S. D. Aster, A. L. Maycock, F. M. Robinson, R. Hirschmann, C. S. Sweet, E. H. Ulm, D. M. Gross, T. C. Vassil, and C. A. Stone, Nature, 288, 280 (1980). 25 P. Bunning, B. Holmquist, and J. F. Riordan, Biochem. Biophys. Res. Comm., 83, 1442 (1978). 26 D. W. Cushman and H. S. Cheung, Biochim. Pharmacol., 20, 1637 (1971). 27 D. W. Cushman and H. S. Cheung, private communication. 28 S. Natarajan, M. E. Condon, M. S. Cohen, J. Reid, D. W. Cushman, B. Rubin, and M. A. Ondetti, in Proceedings of the 6th American Peptide Symposium, E. Gross and J. Meienhofer, Eds., North Holland, Amsterdam, 1979, p. 463. 29 E. W. Petrillo and E. R. Spitzmiller, Tetra. Lett. 4929 (1979). 30 E. W. Petrillo, E. R. Spitzmiller, S. Natarajan, M. Cohen, and M. A. Ondetti, manuscript in preparation. 31 M. E. Condon, J. A. Reid, K. A. Losee, D. W. Cushman, and M. A. Ondetti, Abstracts of the 177th Meeting of the American Chemical Society A.C.S., April 1979, Abstract MEDI—64. 32 M. E. Condon, E. W. Petrillo, Jr., D. E. Ryono, J. A. Reid, R. Neubeck, M. Puar, J. E. Heikes, E. F. Sabo, K. A. Losee, D. W. Cushman, and M. A. Ondetti, J. Med. Chem., submitted for publication. 33 A synthesis of an α-methyl analog of (5–9) is reported by A. Sugie and J. Katsube, Chem. Pharm. Bull., 27, 1708 (1979). 34 I. Mita, J. I. Iwao, M. Oya, T. Chiba, and T. Iso, Chem. Pharm. Bull., 26, 1333 (1978). 35 Y. Funae, T. Komori, D. Sasaki and K. Yamamoto, Jpn. J. Pharmacol., 28, 925 (1978). 36(a). T. Iso et al., Jpn. J. Pharmacol., 30, 136P (1980); (b) Santen Pharmaceutical Co., Ltd., Belgian Pat. 875,365. 37 Santen Pharmaceutical Co., Ltd., U.K. Pat. Appl. GB2027025A. 38 J. T. Suh, J. W. Skiles, B. E. Williams, and A. Schwab, U.S. Pat. 4,256,761. 39 Morton-Norwich Co., Belgian Pat. 883319, cf. Derwent World Patent Index 84362C 40 S. Klutchko, M. L. Hoefle, R. D. Smith, A. D. Essenburg, R. B. Parker, V. L. Nemeth, M. J. Ryan, D. H. Dugan, and H. R. Kaplan, J. Med. Chem., 24, 104 (1981). 41 American Cyanamid German Pat. 2934592, cf. Derwent World Patent Index 22301. 42 Sandoz-Patent-GMBH, Belgian Pat. 871-574; cf. Derwent World Patent Index 33335B. 43(a) T. Sawayama, K. Kinugasa, H. Nishimura, K. Takeyama, and H. Hosoki, U.S. Pat. 4,248,883; (b) F. Bellini and H. U. Immer, U.S. Pat. 4,216,209. 44(a) T. Komiyama, H. Suda, T. Aoyagi, T. Takeuchi, H. Umezawa, K. Fujimoto, and S. Umezawa, Arch. Biochem. Biophys., 171, 727 (1975); (b) C. M. Kam, N. Nishino, and J. C. Powers, Biochemistry, 18, 3032 (1979); (c) N. Nishino and J. C. Powers, Biochemistry, 18, 4340 (1979). 45 R. E. Galardy, Biochem. Biophys. Res. Comm., 97, 94 (1980). 46 B. Holmquist and B. L. Vallee, Proc. Natl. Acad. Sci. USA, 76, 6216 (1979). 47(a) E. W. Petrillo, Jr., M. A. Ondetti, D. W. Cushman, E. R. Weaver, and J. E. Heikes, 176th Meeting of the American Chemical Society, September 1978, Abstract MEDI-27; (b) E. W. Petrillo, Jr., D. W. Cushman, M. Duggan, J. E. Heikes, D. S. Karanewsky, M. A. Ondetti, G. C. Rovnyak, B. Rubin, J. Schwartz, E. R. Spitzmiller, and E. R. Weaver, manuscript in preparation. 48 S. J. Benkovic and E. J. Sampson, J. Am. Chem. Soc., 93, 4009 (1971). 49 N. Nishino and J. C. Powers, Biochemistry, 17, 2846 (1978). 50 M. A. Ondetti, E. F. Sabo, K. A. Losee, H. S. Cheung, D. W. Cushman, and B. Rubin, in Peptides Proc. Fifth American Peptide Symposium, M. Goodman and J. Meienhofer, Eds., Wiley, New York, 1977, p. 576. 51 Tanabe Seiyaku, European Pat. 18549, cf. Derwent World Patent Index 82961C. 52 R. G. Almquist, W. R. Chao, M. E. Ellis, and H. L. Johnson, J. Med. Chem., 23, 1392 (1980). 53 J. W. Ryan, A. Chung, L. C. Martin, and U. S. Ryan, Tissue Cell, 10, 555 (1978). 54 E. M. Arnett, Progr. Phys. Org. Chem., 1, 223 (1963). 55 S. Natarajan, M. E. Condon, M. Nakane, J. Reid, E. M. Gordon, D. W. Cushman, and M. A. Ondetti, Seventh American Peptide Symposium, June, 1981, to appear. 56 M. M. Hann, P. G. Sammes, P. D. Kennewell, and J. B. Taylor, J.C.S. Chem. Comm., 234 (1980). 57 E. Atherton, H. D. Law, S. Moore, D. P. Elliott, and R. Wade, J. Chem. Soc. C, 3393 (1971). 58 K. F. Fok and J. A. Yankeelov, Biochem. Biophys. Res. Comm., 74, 273 (1977). 59 R. K. Ferguson, P. H. Vlasses, B. N. Swanson, D. L. Cooper, R. O. Davies, and W. B. Abrams, Am. J. Cardiol., 47, 470 (1981). 60 J. Biollaz, M. Burnier, G. A. Turini, H. L. Gomex, F. Ferber, C. Fotis, K. H. Jones, P. Lutterbeck, H. Gavras, and H. R. Brunner, Clin. Pharmacol. Ther., 234 (1981). 61 B. Rubin, R. J. Laffan, D. G. Kotler, E. H. O'Keefe, D. A. DeMaio, and M. E. Coldberg, J. Pharmacol. Exp. Ther., 204, 271 (1978). 62 D. W. Cushman and M. A. Ondetti, Biochem. Pharamcol., 29, 1871 (1980). 63 D. M. Gross, C. S. Sweet, E. H. Ulm, E. P. Backlund, A. A. Morris, D. Weitz, D. L. Bohn, H. C. Wenger, T. C. Vassil, and C. A. Stone, J. Pharmacol. Exp. Ther., 216, 552 (1981). 64 B. Rubin, M. J. Antonaccio, and Z. P. Horovitz, in Captopril and Hypertension, D. B. Case, E. H. Sonnenblick, and J. H. Laragh, Eds., Plenum, New York, 1980, pp. 115–135. 65 G. R. Keim, P. L. Sibley, I. H. Zaidi, C. L. Keysser, J. S. Kulezza, Y. H. Yoon, and F. G. Zaki, Soc. Toxicology Animal Conference, Washington, D.C., March 13, 1980. 66 M. J. Antonaccio, B. Rubin and Z. P. Horovitz, Clin. Exp. Hypertension, 2, 613 (1980). 67 B. Rubin, M. J. Antonaccio and Z. P. Horovitz, in Angiotensin Converting Enzyme Inhibitors, Z. P. Horovitz, Ed., Urban and Schwarzenberg, Baltimore-Munich, 1980, p. 27. 68 R. G. Bengis, T. G. Coleman, D. B. Young, and R. E. McCaa, Circ. Res., 43(Supp. I, 45 (1978). 69 C. S. Sweet, D. M. Gross, P. T. Arbegast, S. L. Gaul, P. M. Britt, C. T. Ludden, D. Weitz, and C. A. Stone, J. Pharmacol. Exp. Ther., 216, 558 (1981). 70 Th. Unger, R. W. Rockhold, G. Bönner, W. Rascher, K. Schaz, G. Speck, A. Schömig, and D. Ganten, Clin. Exp. Hypertension, 3, 121 (1981). 71 J. G. Collier, B. F. Robinson, and J. R. Vane, Lancet, 1, 72 (1973). 72 R. K. Ferguson, H. R. Brunner, G. A. Turini, H. Gavras, and D. N. McKinstry, Lancet, 1, 775 (1977). 73 D. B. Brunner, G. Desponds, J. Biollaz, I. Keller, F. Ferber, H. Gavras, H. R. Brunner, and J. L. Schelling, Br. J. Clin. Pharmacol., 11, 461 (1981). 74 J. C. Alexander and J. H. Meyer, in Angiotensin Converting Enzyme Inhibitors, Z. P. Horovitz, Ed., Urban and Schwarzenberg, Baltimore-Munich, 1981, p. 379. 75 D. B. Case, S. A. Atlas, J. H. Laragh, P. A. Sullivan, and J. E. Sealey, J. Cardiovasc. Pharmacol., 2, 339 (1980). 76 K. Chatterjee, R. Ader and W. W. Parmley, in Angiotensin Converting Enzyme Inhibitors, Z. P. Horovitz, Ed., Urban and Schwarzenberg, Baltimore-Munich, 1981, p. 285. 77 J. A. Stritar, in Angiotensin Converting Enzyme Inhibitors, Z. P. Horovitz, Ed., Urban and Schwarzenberg, Baltimore-Munich, 1981, p. 301. 78 O. A. Carretero, A. G. Scidi and S. R. Maitra, in Angiotensin Converting Enzyme Inhibitors, Z. P. Horovitz, Ed., Urban and Schwarzenberg, Baltimore-Munich, 1981, p. 105. 79 C. I. Johnston, M. Yasiyima and B. H. Clappison, in Angiotensin Converting Enzyme Inhibitors, Z. P. Horovitz, Ed., Urban and Schwarzenberg, Baltimore-Munich, 1981, p. 123. 80 M. J. Antonaccio, M. Asaad, B. Rubin, and Z. P. Horovitz, in Angiotensin Converting Enzyme Inhibitors, Z. P. Horovitz, Ed., Urban and Schwarzenberg, Baltimore-Munich, 1981, p. 161. 81 H. R. Brunner, G. A. Turini, B. Waeber and H. Gavras, in Angiotensin Converting Enzyme Inhibitors, Z. P. Horovitz, Ed., Urban and Schwarzenberg, Baltimore-Munich, 1981, p. 351. 82 J. H. Laragh, in Angiotensin Converting Enzyme Inhibitors, Z. P. Horovitz, Ed., Urban and Schwarzenberg, Baltimore-Munich, 1981, p. 403. 83 A. F. Heald and E. C. Ita, Pharmacologist, 192, 129 (1977). 84 T. Unger, R. W. Rockhold, I. Kaufmann-Bühler, D. Hübner, B. Schull, G. Speck and D. Ganten, in Angiotensin Converting Enzyme Inhibitors, Z. P. Horovitz, Ed., Urban and Schwarzenberg, Baltimore-Munich, 1981, p. 55. 85 M. J. Antonaccio and L. Kerwin, Eur. J. Pharmacol., 68, 209 (1980) 86 M. J. Antonaccio and L. Kerwin, Hypertension, to appear. Citing Literature Volume2, Issue1January/March 1982Pages 1-41 ReferencesRelatedInformation

Referência(s)